TET2 and glioblastoma: GSC frequency and self-renewal capacity predict tumor growth capacity in vivo.28 To examine if TET2 inhibition affects the growth of GBM xenografts, the neurosphere lines described above were implanted to caudate-putamen of immune-deficient mice and all animals were sacrificed when the group implanted with TET2 knockdown cells began to show adverse signs of tumor burden.